Join
Live feed
·
PRReleasevia Quantisnow
Anixa Biosciences Inc. logo

Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance

ByQuantisnow·Wall Street's wire, on your screen.
ANIX· Anixa Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANIX (Anixa Biosciences Inc.) and more on Quantisnow.